May 22, 2023
| The Honorable Kevin McCarthy | The Honorable Charles Schumer |
| Speaker | Majority Leader |
| U.S. House of Representatives | U.S. Senate |
| Washington, DC 20515 | Washington, DC 20510 |
| The Honorable Hakeem Jeffries | The Honorable Mitch McConnell |
| Minority Leader | Minority Leader |
| U.S. House of Representatives | U.S. Senate |
| Washington, DC 20515 | Washington, DC 20510 |
Dear Leader Schumer, Speaker McCarthy, Minority Leaders Jeffries and McConnell:
As organizations representing clinical and pathology laboratories, health care providers, laboratory professionals, and diagnostic manufacturers, we urge Congress to take immediate action to pass S. 1000 / H.R. 2377, the Saving Access to Laboratory Services Act (SALSA). This bicameral, bipartisan legislation would update Medicare’s payment system for laboratory services to make it predictable and sustainable, ensuring our nation’s laboratory infrastructure is equipped to support the full range of testing that patients need for day-to-day care as well as during times of public health crisis, while fostering innovation in new diagnostics.
Without congressional action, Medicare reimbursement cuts – a fourth round scheduled to begin January 1, 2024 – could jeopardize access to many clinical laboratory tests that are used to diagnose, monitor, prevent, and manage common diseases for Medicare beneficiaries.
More Advocacy Letters
Advocacy Letter
MGMA testimony on overregulation in healthcare (May 8, 2024)
Advocacy Letter
MGMA to DEA: Issue proposed telehealth rule (April 2, 2024)
